XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Technology development and licensing revenue $ 125,000 $ 125,000
Operating expenses:    
Research and development 2,767,659 2,741,076
General and administrative 2,217,864 1,665,028
Total operating expenses 4,985,523 4,406,104
Loss from operations (4,860,523) (4,281,104)
Other income (expense):    
Gain (loss) from change in valuation of earn-out milestone liability 3,130,000 (270,195)
Fair value of warrants issued in connection with amendment to modify GEN-1 earn-out milestone payments (400,000)
Investment income 113,791 73,724
Interest expense (350,747)
Other income 27 580
Total other income (expense), net 2,493,071 (195,891)
Net loss $ (2,367,452) $ (4,476,995)
Net loss per common share    
Basic and diluted $ (0.12) $ (0.25)
Weighted average shares outstanding    
Basic and diluted 19,104,785 17,683,847